Pro-Alexion Pharmaceuticals Inc Institutional Investors Sentiment Runs High in 2017 Q3January 13, 2018 - By Michael CollierSentiment for Alexion Pharmaceuticals Inc (NASDAQ:ALXN)Alexion Pharmaceuticals Inc (NASDAQ:ALXN) institutional sentiment decreased to 1.17 in 2017 Q3. The institutional investors in our partner’s database reported: 206.89 million shares, down from 208.01 million shares in 2017Q2. Also, the number of institutional investors holding Alexion Pharmaceuticals Inc in their top 10 positions was flat from 17 to 17 for the same number . Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Ratings CoverageRatings analysis reveals 82% of Alexion Pharmaceuticals Inc.’s analysts are positive. Out of 28 Wall Street analysts rating Alexion Pharmaceuticals Inc., 23 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”.

Source: Wall Street Journal January 13, 2018 14:26 UTC